Acorda Therapeutics Reports Second Quarter 2007 Financial Results
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced its financial results for the second quarter 2007.
Financial Results
Corporate Financing – Acorda’s recent secondary offering raised $72.3 million, net of issuance costs, from the sale of approximately 4.2 million shares of the Company’s common stock.